Three types of portable infusers with different infusion mechanisms were evaluated with regard to their accuracy during a hyperbaric oxygenation protocol. The power driving the pump is provided by either a balloon, a spring or a vacuum mechanism. Performance during hyperbaric oxygenation (HBO) varied between the devices, probably due to the difference in driving mechanism. Flow delivery by the vacuum type infuser is substantially affected by HBO. Doubling the ambient pressure approximately doubled flow delivery from the vacuum type device. We suggest that other devices are more suitable for use in this clinical situation. We conclude that it is desirable to check the performance of any infuser intended for use during hyperbaric oxygenation and to be mindful of potential differences among such devices.
Handy, portable infusers are now in worldwide use for patients in many clinical situations such as in pain clinics, for chemotherapy, in perioperative management, and in domestic medicine 1 . Hyperbaric oxygenation (HBO) therapy involves provision of a high concentration of oxygen under a high ambient pressure. Indications for HBO are numerous and include osteoradionecrosis, haemorrhagic radiation cystitis and problem wound healing. Some patients will need to receive a continuous infusion of drugs during HBO. At present, commercially available portable infusers are driven by either vacuum, balloon, or coiled-spring mechanism. Several reports have been published about the accuracy of syringe pumps during HBO 2, 3 . Portable infusers have not been sufficiently assessed for accuracy of flow delivery during HBO. This study evaluated the accuracy of examples of the three types of infuser under conditions commonly used for HBO therapy.
METHODS

Infusers
The three types of infusers used were: Balloon Infuser; Baxter, U.S.A. (balloon-type), Terumotec; Terumo Inst. Tokyo, Japan (spring-type) and Coopdeq; Osaka, Japan (vacuum-type). The balloontype of infuser has a balloon that acts as an elastic reservoir. The reservoir operates with a sustained internal pressure when filled with fluid and it thus should generate a continuous constant flow. The spring-type infuser contains a coiled spring, so that when its reservoir is filled with a drug solution, the spring is compressed, generating flow as a result of the recoil of the spring back toward its original length. The vacuum-type infuser has two chambers divided by a partition and a vacuum is produced in one chamber when the other one is filled with fluid. Using this vacuum power, it generates flow. In each of these devices, the nominal flow rate is regulated by changing the resistance of the outlet tube connected to the reservoir or chamber. The devices are all said by the manufacturers to have an accuracy of ±10%.
In the present study, we set the nominal flow rate at 5 ml/h for the balloon-and spring-types and at 4 ml/h for the vacuum-type. For each type of infuser (balloon, spring and vacuum), a given device was used for only one test run and a total of eight infusers were tested at each pressure. (Figure 1 ) HBO was simulated using the following protocol: 1. Rising-pressure phase: 10 min. 2. Steady pressure of 2 ATA 60 min. 3. Decreasing phase (from 2 ATA to 1 ATA): 15 min.
HBO protocol
Thus, the duration of HBO was 85 minutes. As some types of portable infusers (especially the balloon-type) may have variations in flow delivery when the infusion is started, infusions were commenced 30 minutes before initiation of HBO. Measurements were continued for a total of 160 minutes to assess possible post-HBO effects. Measurements were made noting the following times: T-str: start of infusion (into a measuring device about 30 min before the start of HBO); T-0: start HBO; T-1:
at the end of the 10-min compression phase; T-2:
after 30 min at 2 ATA; T-3:
after the next 30 min at 2 ATA; T-4:
at the end of the 15 min decompression phase; T-5: 15 min after HBO had finished; T-6: 30 min after T-5; "T-pre" represented the duration of the period T-str to T-0. To clarify the role of HBO on the performance of the infusers, we tested each device at 1 ATA over the same time frame (about 160 min).
Measurement of volumes infused (Figure 2)
Each infuser was filled with 60 ml of distilled water (Otsuka Pharm, Japan) and connected to a measuring device by a 15 cm line (Terumo, Japan). In other reports, the resistance of the infuser's outlet had a large influence on its accuracy, so the infuser was set above the top of the measurement device. As temperature may have a significant effect, the temperature was maintained between 24 and 27°C during the measurements. Measurements were performed using two devices made of glass: these were incised with 0.2 ml divisions. The water was infused into the measuring device through an inflow tube near its base. Before flow measurements started, sufficient water was poured into the measuring device to bring the water surface up to the lower end of the incised scale.
We calculated the flow rate using the following formula:
Flow rate (% of nominal)=(V TB-V TA) x 100/Vn V TB=Total volume at end of measuring period V TA=Total volume at end of previous measuring period Vn =Calculated volume delivered (during period) if infusion rate=set rate.
Statistical analysis
Data are expressed as mean±standard deviation (SD). A one-way analysis of variance with repeated measures was performed within each group. A twoway analysis of variance with repeated measures was used to assess the effects of altering the ATA level 
RESULTS
Performance during HBO
No disturbances, such as sudden stops in delivery or rupture of the balloon or reservoir, were seen during the infusions.
Pump stability pre-HBO
The vacuum-type pump had a small statistically significant difference in flows in the T-pre phases (P=0.037) comparing the no HBO sequence versus the HBO sequence. This difference was not thought to be clinically important or significant in terms of assessment of the effect of HBO as the pump provided stable infusion rates within each measurement period. (Although HBO did have an effect, see below, the infusion was relatively constant during each "steady state" period.)
Accuracy of delivery at two different ambient pressures (a) Balloon-type
At 1 ATA (Balloon-type, 1 ATA in Figure 3 ), the flow rate showed significant variations with time (repeated-measures ANOVA). The variations were between 20 and 30% above the nominal rate as has been previously reported. We did not see a significant difference between flow rate at 2 ATA (Balloon-type, 2 ATA in Figure 3 ) and the rate in the corresponding time-period at 1 ATA. However, the two-way ANOVA revealed an interaction between the intergroup difference (1 ATA vs 2 ATA) and time, (in other words, the way in which flow rate varied with time differed between 1 ATA and 2 ATA). In fact, at 2 ATA there was a transient tendency for an increase in the flow rate at T-5. However, we did not see this tendency at 1 ATA (Figure 3 ).
(b) Spring-type
The flow rate varied with time at 1 ATA (repeatedmeasures ANOVA), the variations from the nominal rate being within the range±5% (Spring-type, 1 ATA in Figure 3 ). As with the balloon-type, this variation was consistent with previous reports. A significant difference was detected between 1 ATA and 2 ATA (P=0.043, repeated-measures ANOVA) but we did not see a significant difference in flow rate within a given time-period at 2 ATA or 1 ATA (multiple analysis). At 2 ATA, the mean values obtained for actual flow rate were within 5% of the nominal rate (Spring-type, 2 ATA in Figure 3 ).
(c) Vacuum-type
At 1 ATA (Vacuum-type, 1 ATA in Figure 3 ), there was no significant variation in flow rate with time. However, we saw a large and significant difference in flow rate between 2 ATA and 1 ATA (Vacuum-type, 2 ATA in Figure 3 ). At T-2 and T-3 during HBO, flow rate was about twice the corresponding value recorded at 1 ATA. After HBO had ended, it returned to the level previously seen at 1 ATA. The infuser was positioned above the top of the measuring device, ensuring that the infuser could not be lower than the (rising) water surface during the measurements. Nominal flow was set using the regulator.
Measuring Device
Regulator DISCUSSION Portable infusers are used in many clinical situations. Some caution is necessary in using these devices as their performance may be influenced by factors such as temperature, output resistance and kind of fluid used. The manual supplied with the Baxter Infuser warns the user about these influences. As the infusers currently available generate flow using a number of different mechanisms, differing circumstances may have different effects on the performance of different infusers. Hyperbaric oxygen has been in clinical use for 40 years and its use is increasing. There is a lack of published information on the performance of portable infusers under HBO conditions.
Our results demonstrate significant differences in flow rate associated with HBO in the vacuum-type infusers but not the other devices. The effect of HBO on the infusion rate of the vacuum-type infusers was so large (2 ATA approximately doubled pump output) that we would consider this device unsuitable for use during HBO. In the other two types of infusers, the effect of changing the ambient pressure was minimal.
In our institute, HBO is usually performed at 2 ATA. In different institutions (and in different countries), HBO may be performed using several different pressures. We examined 2 ATA because we treat most patients at 2 ATA. The effects of higher ATA on infuser performance will require further study.
In conclusion, our results show that flow delivery by the vacuum type infuser is substantially affected by HBO. We suggest that other devices are more suitable for use in this clinical situation. The balloon-type and coiled-spring infusers showed relatively small changes in flow rate in relation to HBO and would seem to be suitable for use during HBO, at least under the conditions employed in this present study. Before clinical use during HBO, the performance of portable infusers at appropriate pressures should be checked.
